Who
Brian J. Donnelly
Chief Commerical Officer
Company insider
Files Form 4 as: Chief Commerical Officer, Myriad Genetics.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 May 2025
- Last trade
- 11 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 12 Jun 2026 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code A | $20K5,000 at $3.94 | filing |
| 11 Jun 2026filed 12 Jun 2026 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code A | $20K5,000 at $3.94 | filing |
| 1 May 2026filed 4 May 2026 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $269K55,975 at $4.80 | filing |
| 1 May 2026filed 4 May 2026 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $269K55,975 at $4.80 | filing |
| 12 Mar 2026filed 16 Mar 2026 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code A | —226,804 at $0.00 | filing |
| 12 Mar 2026filed 16 Mar 2026 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code A | —226,804 at $0.00 | filing |
| 1 May 2025filed 2 May 2025 | MYGN Myriad Geneticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —236,167 at $0.00 | filing |
| 1 May 2025filed 2 May 2025 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code A | —269,905 at $0.00 | filing |
| 1 May 2025filed 2 May 2025 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code A | —127,629 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.